(1)
Impact of Etelcalcetide on Cardiovascular Outcomes and Mortality in Hemodialysis Patients With Secondary Hyperparathyroidism: A Meta-Analysis. OAIJMR 2025, 5 (1), 41-54. https://doi.org/10.37275/oaijmr.v5i1.701.